believ altria deliv averag ep growth driven price cost
save buyback equiti incom believ oper look strong price
flexibl across portfolio address potenti econom stress consum
see risk dividend given strong oper cash flow healthi balanc sheet
suspend buyback rais ep beat partial
off-set cut buyback maintain ep target
see risk dividend manag bit vagu
commentari dividend outlook limit withdraw guidanc
big compon withdraw guidanc abi guidanc abi ep
contribut much signific altria cash contribut expect littl
chang board think around dividend given cash flow balanc
sheet strength cash convers oper expect altria dividend
least flat possibl increas later year normal schedul
price mix lever add flexibl time econom stress expect altria
monitor statu low end consum adjust promot spend
coupon needed/appropri took similar approach last recess even
low end consum still struggl launch marlboro black
marlboro special blend ad introductori discount keep consum
marlboro franchis take similar approach year includ marlboro
bold recent launch nation assum smokeabl segment
price/mix nearli deceler averag
tax advantag could drive favor econom sale solid
growth momentum chart insid expect growth continu altria expand
distribut though ten state nicotin pouch tax total cost favor
vs cigarett feder excis tax help drive favor econom
scale expect similar margin current moist snuff product altria plan
submit pmta may capac expans gener track
oper core busi still solid retail cigarett volum declin moder
recent chart insid categori volum declin moder
iqo still small momentum grow chart insid fda
approv mrtpa potenti posit catalyst could also drive favor tax
treatment though time unclear like delay includ zero
contribut juul estim therefor pose downsid risk ep
unfavor regul disrupt excis tax hike gain illicit trade risk profit
altria commerci tobacco product us brand like marlboro skoal
price target ep
current multipl
ep expect altria deliv three-
year averag sale growth averag
revenu exclud excis tax
piper sandler seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
altria expand distribut drive sale growth allow compet
evenli zyn lead oral nicotin product far good initi traction
consum prefer smaller pouch size compar zyn discret
rectangular packag differenti expect altria provid market support
point sale display price promot induc trial direct mail adult smoker
databas us measur retail sale latest four week end april per
iri exhibit continu grow behind expand distribut
volum declin
us cigarett categori volum declin moder sinc march low exhibit next
page volum declin recent week end april per iri potenti
benefit recent stockpil hard know larg cash outlay need signific
stockpil typic beyond reach consum higher unemploy covid-
risk volum mix altria enhanc data analyt revenu manag
capabl help manag price navig recess like altria vast
databas adult us smoker data zip code level inform price
coupon strategi altria monitor manag mix revenu manag system
page
cigarett categori volum declin measur us retail channel
flow low incom
iqo us sale
small move
right direct
low-incom worker collect unemploy benefit could actual
earn money unemploy would kept work given structur
addit benefit govern stimulu bill boost feder unemploy benefit
per week week juli boost annual
increment current feder unemploy benefit typic cover worker prior
wage threshold regular unemploy benefit typic last week could
extend week qualifi addit household earn less
also receiv stimulu check depend household size
us iqo sale still small sequenti growth measur retail sale encourag
exhibit next page consid steadi improv posit indic traction
consum close iqo store could shift heatstick purchas
measur retail channel like also reflect acceler consum demand believ
iqo drive increment share gain especi menthol alreadi half recent
retail sale vs altria cigarett volum fda approv iqo modifi risk tobacco
product applic mrtpa could signific catalyst potenti support favor
excis tax structur vs cigarett alreadi place ct ky nc wa nm ut
page
iqo sale measur us retail channel
page
excis tax rev
good
cog percent sale
net incom attrib noncontrol int
net incom attrib altria
earn attribut share-bas award
current disclosur inform compani found www pipersandl com/researchdisclosur
